Treatment of neurological disorders

GB2703108APending Publication Date: 2026-07-15CEREBROVIA THERAPEUTICS LTD
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
GB · GB
Patent Type
Applications
Current Assignee / Owner
CEREBROVIA THERAPEUTICS LTD
Filing Date
2025-04-07
Publication Date
2026-07-15
Patent Text Reader

Abstract

The present disclosure relates to the treatment of neurological disorders, including post-concussion syndrome, chronic traumatic encephalopathy, mild traumatic brain injury, and single or multiple head trauma. Described is the combinatorial use of a racetam and a first generation H1 receptor antihistamine, including products comprising the same. [Figure 3]
Need to check novelty before this filing date? Find Prior Art